Physiomics (GB:PYC) has released an update.
Physiomics PLC has enhanced its service offerings with the launch of a new Biostatistics service and the expansion of its Data Science and Bioinformatics services, which are vital for supporting drug development and personalized medicine. The company, known for its mathematical modelling and data science expertise, aims to further support clinical research and address the increasing complexity of drug development data. This strategic move is designed to boost the company’s growth by providing a more comprehensive range of services to its clients.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
